Takemura K, Aoyagi K, Nagase S, Gotoh M, Hirayama A, Ueda A, Tomida C, Koyama A
Department of Internal Medicine, Kamitsuga General Hospital, Kanuma City, Tochigi, Japan.
Nephron. 1998;78(1):82-7. doi: 10.1159/000044886.
A state of peroxidation is one of the factors contributing to uremia. For example, we have reported that certain species of reactive oxygen, particularly the hydroxyl radical, play an important role in the biosynthesis of methylguanidine which contributes to toxicity in patients with uremia. However, it is uncertain which enzymes are involved in the synthesis of methylguanidine from creatinine. In this study, we attempt to show methylguanidine synthesis in the presence of peroxisomal enzymes that catalyze the beta-oxidation of fatty acids. In addition, we investigate the effect of clofibrate, which induces peroxisomal enzymes or glutathione peroxidase activity, on methylguanidine synthesis in the peroxisomal fraction. Male Wistar rats were fed with the chow containing 0.5% clofibrate to induce peroxisomal enzymes and control rats were fed with ordinary laboratory chow. Peroxisomal fractions were obtained from liver homogenates by centrifugation, and incubated with creatinine in 0.1 M potassium phosphate buffer pH 7.4 at 37 degrees C. Results show that methylguanidine is synthesized from creatinine concomitant with the synthesis of hydrogen peroxide from endogenous substrates in the peroxisomal fraction. This methylguanidine synthesis is inhibited by the addition of dimethylsulfoxide, glutathione, or sodium azide (p < 0.01). The rate of methylguanidine synthesis in clofibrate-treated rats was significantly less than that in control rats (p < 0.02). These results suggest that methylguanidine is synthesized in the peroxisomal fraction, and reactive oxygen species which are generated through this enzymatic reaction, participate in methylguanidine synthesis. Moreover, the induction of a scavenger system, especially glutathione peroxidase takes precedent over the generation of reactive oxygen species in peroxisomes treated with clofibrate.
过氧化状态是导致尿毒症的因素之一。例如,我们曾报道某些活性氧物种,特别是羟基自由基,在甲基胍的生物合成中起重要作用,而甲基胍会导致尿毒症患者中毒。然而,尚不确定哪些酶参与了从肌酐合成甲基胍的过程。在本研究中,我们试图展示在催化脂肪酸β-氧化的过氧化物酶存在的情况下甲基胍的合成。此外,我们研究了诱导过氧化物酶或谷胱甘肽过氧化物酶活性的氯贝丁酯对过氧化物酶体组分中甲基胍合成的影响。给雄性Wistar大鼠喂食含0.5%氯贝丁酯的饲料以诱导过氧化物酶,给对照大鼠喂食普通实验室饲料。通过离心从肝脏匀浆中获得过氧化物酶体组分,并在37℃下于pH 7.4的0.1 M磷酸钾缓冲液中与肌酐孵育。结果表明,在过氧化物酶体组分中,甲基胍是从肌酐合成的,同时伴随着过氧化氢从内源性底物的合成。添加二甲基亚砜、谷胱甘肽或叠氮化钠可抑制这种甲基胍的合成(p<0.01)。氯贝丁酯处理组大鼠的甲基胍合成速率显著低于对照组大鼠(p<0.02)。这些结果表明,甲基胍是在过氧化物酶体组分中合成的,并且通过这种酶促反应产生的活性氧参与了甲基胍的合成。此外,在用氯贝丁酯处理的过氧化物酶体中,清除剂系统(尤其是谷胱甘肽过氧化物酶)的诱导优先于活性氧的产生。